Zhigang Wang
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.
Journal: Journal of Crohn's & colitis
Published: March 24, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease.
Journal: Clinical pharmacokinetics
Published: January 09, 2026
Optimizing the switch from escalated intravenous to subcutaneous infliximab: a population pharmacokinetics-pharmacodynamics study.
Journal: Journal of Crohn's & colitis
Published: August 28, 2025
Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn's Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: April 15, 2025
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease.
Journal: Pharmaceutics
Published: December 06, 2024
A Risk Stratification Tool for Relapse After Intravenous-To-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases.
Journal: The American journal of gastroenterology
Published: November 28, 2024
The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 29, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Journal: Therapeutic drug monitoring
Published: October 29, 2023
Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle.
Journal: Inflammatory bowel diseases
Published: May 23, 2023
Clinical treatment of lumbar disc herniation.
Journal: Annali italiani di chirurgia
Published: September 26, 2022
Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 06, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 08, 2022
Last Updated: 09/26/2026